Professor Fadi Salloum
Richmond (United States of America)
Follow
Contributor content
Journal
Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism
10 January 2017
